Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Free Dating
Ñompany Maksim-LLC. Ýëåêòðîïðèâîäû. Made and sell.
Popular Articles

American Indian Tribes To Get $500M In Stimulus Funds For Health Projects
Newly appointed IHS Director Yvette Roubideaux on Friday announced that American Indian tribes will receive $500 million as part of the $787 billion economic stimulus package to fund health care projects, the Green Bay Press-Gazette reports. According to the Press-Gazette, American Indian tribes frequently cite lack of adequate health care as a major issue on reservations. President Obama also included a $454 million increase for IHS programs in his 2010 budget proposal to address such barriers.The $500 million includes:
new payday loan lenders
Proposed California Budget Cuts To State HIV/AIDS Programs Will 'Cost Lives', Opinion Piece Says
"California will not be saving money," in its proposal to cut funding from HIV/AIDS programs, including the state AIDS Drug Assistance Program, Ken Owens, member of the Inland Empire HIV Planning Council and former member of the Desert AIDS Client Committee, writes in a Desert Sun opinion piece. He adds, "Instead, it will have more people looking for places to live and needing more state services because they are sick, need welfare funds and state healthcare." Owens continues, "Their plan of balancing the budget will surely cost lives if HIV/AIDS funding is cut" (Owens, Desert Sun, 6/18).
News of the day
BioLineRx Announces Positive Preliminary Results From The Phase I/II Trial Of BL-1040
BioLineRx Ltd. (TASE:BLRX), a clinical stage drug development company, today announced positive preliminary results from the ongoing phase I/II clinical trial designed to assess the safety and feasibility of BL-1040, the first injectable device designed to address cardiac remodeling, in 20- 30 patients at several sites in Germany and Belgium. To date, 15 patients were successfully treated with BL-1040 with no complications. Moreover, six months follow up results from the first 5 patients show BL-1040"s efficacy in preventing cardiac remodeling and preserving cardiac function.
Cardiovascular

Wiley-Blackwell To Publish Journal Of Diabetes Investigation

Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), has announced that it will be publishing a new diabetes journal titled Journal of Diabetes Investigation from 2010. Published bi-monthly, the official journal of the Asian Association for the Study of Diabetes (AASD), Journal of Diabetes Investigation will publish both basic and clinical research in diabetes - including a variety of original research, country reports, commentaries, reviews; mini-reviews case reports letters as well as editorials and news. The President of the AASD, Professor Yutaka Seino, said, "The rapid increase in the number of diabetes patients will dramatically impact the medical profession in Asia and will require increasing research on the disease specifically among Asians. The AASD will aggressively promote research activity with the aim of promptly improving diabetes treatments and care for a vast number of Asian patients." The Editor-in-chief of the journal, Nigishi Hotta, said, "The journal will have an international editorial team of experts from the AASD countries and beyond, and will embrace clinical and experimental research in diabetes and its related areas - including aspects of prevention, treatment, education, nutrition, metabolic risk, psychosocial and socio-economic research, as well as molecular aspects and pathophysiology. We seek to develop Journal of Diabetes Investigation to position it as the core diabetes journal of Asia. Wiley-Blackwell, with its international publishing expertise and experience of publishing in cooperation with medical societies in Asia, is the ideal partner to enable the editorial board to meet its goals." The President of the Japan Diabetes Society, Professor Takashi Kadowaki, added, "We are delighted to be publishing with Wiley-Blackwell and look forward to working with the team to communicate ground- breaking research and exciting discoveries to the world"s research communities and health care professionals." The Medical Editorial Director of Wiley-Blackwell, Neil Christensen, remarked, "The significant society involvement - in addition to an editorial board of such high caliber - will make this a project to be reckoned with in terms of authority. We"re very well positioned to help the Journal of Diabetes Investigation realize its full potential and increase its visibility to readers both within North Asia as well as worldwide. The addition of this journal will also strengthen our position as a leading publisher of choice for societies and organizations focused on all aspects of diabetic health and endocrinology research. "ò€‚ò€‚ò€‚ Wiley-Blackwell


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009